Cyclobenzaprine Hydrochloride
Product Images NDC 68071-2596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68071-2596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2596 1)

Pdp (68071 2596 1)
Label for Cyclobenzaprine Hydrochloride 7.5 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 15 round white tablets, each debossed with 'W52' on one side and 'TV' on the other. It includes storage instructions to keep at controlled temperature 68-77°F and a warning to keep out of reach of children. Manufacturer information notes Teva Czech Industries, s.r.o. in the Czech Republic.*
FDA Label Image

Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)

Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)
Chemical structure of Cyclobenzaprine Hydrochloride, showing its molecular arrangement including fused aromatic rings and side chains. The chemical formula is C20H21N·HCl with a molecular weight of 311.9.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.